MediciNova Inc expected to post a loss of 9  cents a share - Earnings Preview

Medicinova

14/02/2022 22:19

* MediciNova Inc  MNOV.OQ   MNOV.O  is expected to show no
change
in quarterly revenue when it reports  results on February 16
(estimated). 
    * ​Refinitiv's mean analyst estimate for MediciNova Inc is
for a
loss of 9 cents per share. For the same quarter last year, the
company reported a loss of 6 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for MediciNova
Inc is
$12​, about 79.8% above​ its last closing price of $2.42. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021              -0.09      -0.07     Beat    22.2
 Jun. 30 2021  -0.09       -0.09      -0.09     Met     -3.8
 Mar. 31 2021  -0.08       -0.08      0.00      Beat    100​
 Dec. 31 2020              -0.09      -0.06     Beat    36.7
 ​​Sep.        -0.11       -0.12      -0.08     Beat    33.3
 30 2020                                                
 Jun. 30 2020  -0.15       -0.10      -0.10     Met     0​
 Mar. 31 2020  -0.08       -0.08      -0.06     Beat    25
 Dec. 31 2019  -0.08       -0.08      -0.05     Beat    37.5
 This summary was machine generated February 14 at 22:19 GMT. 
All figures in US dollars  unless otherwise stated